# Exendin PET/CT for Imaging of Paragangliomas

> **NCT05418907** · — · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 10 (estimated)

## Conditions studied

- Paraganglioma

## Interventions

- **RADIATION:** 68Ga-NODAGA-exendin-4 PET/CT

## Key facts

- **NCT ID:** NCT05418907
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2024-12-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05418907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05418907, "Exendin PET/CT for Imaging of Paragangliomas". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05418907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
